Search NLS News

The company has announced the appointment of its current Chairman Torbjørn Bjerke as its new Chief Executive Officer, effective as from the Annual General Meeting to be held on May 25. Torbjørn Bjerke succeeds Jeppe Øvlesen, who will remain a committed shareholder of the company. The Nomination Committee will also propose to the Annual General […]

The company has been awarded a grant from the Swedish innovation programs, SWElife and MedTech4Health in a collaboration with Danderyd hospital, Huddinge hospital and Karolinska Institute. The grant will fund a further clinical trial of its antibiotic free treatment pHyph for the treatment of vulvovaginal candida infections (VVC). The new study, involving 26 patients with VVC […]

Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development. Access to this funding ensures that momentum of clinical development of Modus’ lead asset, sevuparin, will be enhanced while the company continues to explore licensing and partnership opportunities, it states. These future development plans include preparation for a Phase 2a study evaluating sevuparin […]

Digital therapeutics, the costs of gene and cell therapies, and a challenging financing situation were some of the hot topics in 2023 that SwedenBIO sniffed out at J.P. Morgan’s annual healthcare meeting in San Francisco. The international life sciences year started off with J.P. Morgan’s Annual Healthcare week, which drew thousands of life science experts […]

Oncopeptides has received a research grant of 3 million SEK from Sweden’s Innovation Agency (Vinnova), to explore the development of new treatment options for glioblastoma, an aggressive and incurable form of brain cancer. The grant enables exploratory research to better understand the potential of the PDC platform in solid tumors such as glioblastoma. “We are […]

With more freight moving around the world than ever, combined with increased external circumstances causing supply chain disruptions, there’s never been such pressure on the success of temperature controlled logistics as there is now. NLS sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive […]

The company has presented data from two patients with liver metastases of colorectal cancer origin treated with ACT in the clinical Phase I ACTIVATE trial. The presented radiological results from these two patients suggest an improved response to standard of care chemotherapy in the tumors that are exposed to ACT treatment. This aligns well with […]

Vakona has been given a capital injection from five investors to help it develop a new drug to treat acne. “This is a significant investment for us, as now we can continue with our product development,” says Gabriella Persson, CEO of Vakona. Three of the investors, Stoaf III SciTech, Partnerinvest Norr and Phase2Phase Biopharma, have […]

Niels Abel Bonde, General Manager Novo Nordisk Sweden, will be elected new Chairman of the Board of Directors of Medicon Valley Alliance (MVA) at the upcoming 2023 Ordinary General Meeting. As the only candidate for the chairmanship and with unanimous support from the current board members representing the majority of the votes, Niels Abel Bonde […]

The company has announced an increased focus on its strategy around its core AI capabilities allowing fast and de-risked development of its pipeline. Recently, Evaxion announced that the company has used its AI technology to discover a new treatment opportunity that may broaden cancer immunotherapy. Through new cancer targets, so-called ERVs (endogenous retroviruses), it may […]